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Abstract 
Scleroderma is a generalized autoimmune disease with variable involvement of the skin 
and major organs (esophagus, lung, heart and kidney). Scleroderma is essentially a skin 
disease that frequently involves the digestive system. In scleroderma, the esophagus is 
the most frequently affected organ of the digestive system, and esophageal dysmotility, 
reflux and stricture may be observed in the advanced stage. Balloon dilatation and 
bougienage are generally sufficient in patients developing stricture, and the number of 
cases in whom resection is performed is very low. In a 20-year-old patient with difficulty 
in taking even liquid foods, tests revealed sclerodermal involvement of the distal end of 
the esophagus and stricture. Esophageal resection and gastric replacement were 
performed. Such systemic diseases as scleroderma, although rare, must be considered in 
the differential diagnosis of nonmalignant dysphagia, and resection must be borne in 
mind as a surgical option in cases of advanced stricture. 
 
Introduction 
Systemic sclerosis or scleroderma is an autoimmune disease whose main clinical 
symptom is thickening and hardening of the skin. It may involve several vital organs (for 
example, the lung, heart, kidney, esophagus and intestine) and lead to progressive 
irreversible fibrosis in connective tissue [1–4]. Its etiology and pathogenesis are still 
largely unknown. The histological characteristic of the disease in the early stages is 
characterized by perivascular inflammation and endothelial call apoptosis, while in 
advanced cases it appears as excessive collagen accumulation in the skin and visceral 
organs [1]. It has two subgroups: diffuse systemic sclerosis, and limited disease with 
gastrointestinal manifestations possible in the subgroup. Clinically significant 
gastrointestinal involvement appears in around 50% of patients diagnosed with 
scleroderma in long-term follow-up [2]. This assumes the form of esophageal dysmotility,  
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lower esophageal sphincter insufficiency, reflux, stricture, a reduction in motility in the 
intestine, wide-mouthed diverticles in the large intestine and rectal atonia in advanced 
cases [5]. The esophagus is the most frequently affected organ in the digestive system (75–
90%) [3]. 
A review of the English language literature revealed very few cases with scleroderma 
causing stricture to such an extent that it created difficulties in taking liquid foods, and 
thus, gastric replacement was performed. This report presents a rare case of scleroderma, 
a type of skin disease that narrowed the esophagus to the extent of obstructing intake of 
liquid foods, and our surgical experience in the light of data from the literature. 
Case Report 
A 20-year-old male patient who had difficulty in swallowing solid foods for 2 years and liquid foods 
for the last four months was admitted to our clinic. On physical examination, cachexia, ‘mouse-face’ 
appearance, ulceration in the distal phalanges (fig. 1a) and metacarpo-phalangeal joint ulceration 
(fig. 1b) were identified. Almost full obstruction of the distal 1/3 of the esophagus and stricture were 
determined on barium images (fig. 2a). Esophageal endoscopy demonstrated hyperemia, fragility, 
edema and extreme narrowness at 29 cm obstructing the passage of the endoscope. In addition, 
localized ulcerated areas of mucosa were observed (fig. 2b). The endoscopic biopsy result indicated 
esophagitis. On thoracic CT, there was wall thickening in the distal part of the esophagus (fig. 2c). Apart 
from the skin test results, no findings of involvement of any other internal organ were determined. In 
serological analysis, Scl-70 and antinuclear antibody spotted form were positive. Skin biopsy results 
showed thinning in the epidermis and increased collagen-rich connective tissue in the dermis and 
around the subdermal sweat gland. All of these findings were compatible with scleroderma. 
The patient was diagnosed as suffering from scleroderma. Therefore, the use of a proton pump 
inhibitor, D-penicillamine and nifedipine was started, and a balloon dilatation procedure was 
performed. The patient returned with increased complaints after 35 days. A second balloon dilatation 
procedure was performed, yet the complaints did not improve during follow-up. Consequently, surgery 
was planned. 
Laparatomy, right thoracotomy with subtotal esophagectomy, proximal gastrectomy and 
esophagogastrostomy were performed, and a 12-cm segment was resected (fig. 3a). During the 
dissection of the distal esophagus, advanced mediastinal adhesion and periesophageal mediastinal 
fibrosis were observed (fig. 3b). 
In histopathological examination of the material (fig. 3b), microscopic investigation demonstrated 
fibrous thickening of the esophageal wall, particularly the submucosa, with atrophy of the muscularis 
propria; atrophy and fragmentation of the smooth muscle began in a patchy distribution to a greater 
extent in the circular rather than the longitudinal muscle layer. There was diffuse collagen infiltration 
and fibrosis and the number of gap junctions located between the smooth muscle cells had decreased, 
resulting in fibrosis and thickening of the serosal layer. There was a pathological change in the 
vasculature, especially in the small arteries. The intima was enlarged concentrically with proliferation, 
and the endothelial cells were swollen. The adventitia had developed a fibrotic cuff around the artery, 
which might have obliterated the periarterial capillaries and lymphatics. In the histopathological 
analysis, these findings were reported as sclerodermal involvement of the esophagus. No pathological 
changes within surgical limits were determined. 
The patient was discharged without complications on postoperative day 12. He was started on 
900 mg/day D-penicillamine and 20 mg/day nifedipine preoperatively and discharged with the same 
treatment. No recurrence was observed for two years of follow-up and in periodic check-ups with 
endoscopy and barium imaging. 
Discussion 
The main symptom of scleroderma appears in the skin, and it is regarded as a skin 
disease. It may be seen at any age, though more often in middle age. It is more frequent in  
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women. The commonest initial manifestation of the disease is Raynaud’s phenomenon. In 
the advanced stage of the disease, lung, kidney and heart involvement may lead to death 
[1, 2, 6]. Gastrointestinal system involvement is frequently observed. Esophageal 
involvement in adults accounts for nearly 75–90% of cases. The distal 2/3 of the 
esophagus is frequently affected [3, 5]. 
In scleroderma, motility impairment appears as the result of damage arising in the 
esophageal wall and collagen tissue. The true pathology is muscle fibre atrophy, collagen 
accumulation in connective tissue, and subintimal arterial fibrosis. Arteriole changes in 
the vasa nervorum and collagen accumulation-related neural dysfunction occur. 
Although the picture appears myogenic, it follows a course with degeneration in 
Auerbach’s plexus. Esophageal emptying is delayed due to ineffective peristaltic 
movements; lower esophageal sphincter pressure falls and gastroesophageal reflux 
develops [7]. Related to this, candida esophagitis, erosive esophagitis, Barrett’s esophagus, 
diverticles, fibrous stricture, and malignancy may develop as complications. 
Macroscopically, findings particular to a widened esophagus are determined. The 
radiological finding is esophageal atonia. Stricture and findings compatible with 
esophagitis may be determined in endoscopic examination. Manometrically, 
low-amplitude peristaltic contractions and a reduction in lower sphincter pressure are 
typical [6, 7]. Pyrosis, dysphagia, acid regurgitation, aspiration, chest pain, nausea, and 
vomiting are complications frequently encountered with esophageal involvement of 
scleroderma. Difficulty in swallowing is the cardinal symptom in patients developing 
stricture [5–7]. 
The basic pathogenesis in esophageal involvement of scleroderma is reflux, and the 
development of esophagitis is inevitable in long-term untreated reflux. Therefore, the 
basic principle for esophageal involvement of scleroderma is medical treatment to prevent 
reflux esophagitis. In addition to conservative measures such as diet, eating little amounts 
but often and lying with the head elevated, antacid drugs, prokinetic agents and mucous 
protecting drugs are available. In cases in whom no results are obtained with medical 
treatment, antireflux surgery is an option. Antireflux operations are known to relieve the 
symptoms but not to provide a total cure [3, 7, 8]. 
The long-term complication in untreated reflux and esophagitis is stricture. Peptic 
strictures are the most frequently seen benign strictures of the esophagus. However, the 
realization that reflux is the main element in the mechanism by which stricture arises and 
the use of proton pump inhibitors and H2 receptor blockers has recently lowered the level 
of peptic stricture [9]. In addition to peptic stricture, trauma (spontaneous rupture, 
foreign body, iatrogenic), corrosive ingestion, postirradiation, inflammatory, webs 
(Plummer-Vinson, Schatki’s ring, keratotic) and collagen tissue diseases may be included 
in the etiology of acquired esophagus stricture [10]. The first treatment principle of choice 
in stricture is balloon dilatation and bougienage. In young patients in particular, it is 
more difficult to dilate the strictures, and there is a need for frequent dilatation [9]. 
Resection must be considered in cases of untreatable recurrent stricture. In addition to 
recurrent stricture, resection indications in esophageal strictures may be undilatable 
strictures, strictures with a risk of perforation if dilated, increased stricture dilatation 
frequency, serious dysplasia and suspicion of malignancy [10]. If surgical resection is 
required, the stomach, jejunum and colon may be used as replacement organs. It should 
also be kept in mind that the jejunum and colon may be involved in scleroderma as well 
[11]. 
Drug therapy must be added to surgical treatment of stricture in order to prevent 
recurrence. The treatment of scleroderma has evolved considerably. Specific treatment  
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using immunomodulators have provided good outcome. D-penicillamine is the agent 
from which the most satisfactory results have been obtained. Nifedipine should be added 
to treatment in patients with Raynaud’s phenomenon [4, 12]. 
Systemic diseases such as scleroderma must be borne in mind when examining the 
etiology of nonmalignant dysphagia of the esophagus. In cases developing advanced and 
undilatable stricture, as did our patient, esophagectomy may be the best treatment option. 
 
 
 
 
 
Fig. 1. The patient’s distal phalanges (a) and ulceration in the metacarpo-phalangeal joints (b). 
 
 
 
Fig. 2. Almost total obstruction in 1/3 of the distal section on barium images of the esophagus (a), 
mucosal ulcerations and advanced narrowing of the lumen in endoscopic evaluation (b) and 
esophageal wall thickening giving a mass impression on thoracic CT image (c). 
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Fig. 3. a The surgical material removed. b The picture of the distal esophagus of our patient with 
scleroderma showing the tendency of smooth muscle bundles to have central atrophy (Masson 
trichrome staining, ×200). 
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